195 related articles for article (PubMed ID: 29091270)
1. A high throughput method to study the physiology of E2:ERα signaling in breast cancer cells.
Leone S; Busonero C; Acconcia F
J Cell Physiol; 2018 May; 233(5):3713-3722. PubMed ID: 29091270
[TBL] [Abstract][Full Text] [Related]
2. Unexpected Impact of a Hepatitis C Virus Inhibitor on 17β-Estradiol Signaling in Breast Cancer.
Bartoloni S; Leone S; Acconcia F
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32408555
[TBL] [Abstract][Full Text] [Related]
3. A functional drug re-purposing screening identifies carfilzomib as a drug preventing 17β-estradiol: ERα signaling and cell proliferation in breast cancer cells.
Busonero C; Leone S; Klemm C; Acconcia F
Mol Cell Endocrinol; 2018 Jan; 460():229-237. PubMed ID: 28760601
[TBL] [Abstract][Full Text] [Related]
4. Modulation of 17β-Estradiol Signaling on Cellular Proliferation by Caveolin-2.
Totta P; Gionfra F; Busonero C; Acconcia F
J Cell Physiol; 2016 Jun; 231(6):1219-25. PubMed ID: 26480297
[TBL] [Abstract][Full Text] [Related]
5. Activation of ClC-3 chloride channel by 17β-estradiol relies on the estrogen receptor α expression in breast cancer.
Yang H; Ma L; Wang Y; Zuo W; Li B; Yang Y; Chen Y; Chen L; Wang L; Zhu L
J Cell Physiol; 2018 Feb; 233(2):1071-1081. PubMed ID: 28419445
[TBL] [Abstract][Full Text] [Related]
6. In silico screening for ERα down modulators identifies thioridazine as an anti-proliferative agent in primary, 4OH-tamoxifen-resistant and Y537S ERα-expressing breast cancer cells.
Busonero C; Leone S; Bianchi F; Acconcia F
Cell Oncol (Dordr); 2018 Dec; 41(6):677-686. PubMed ID: 30182339
[TBL] [Abstract][Full Text] [Related]
7. Anticipatory estrogen activation of the unfolded protein response is linked to cell proliferation and poor survival in estrogen receptor α-positive breast cancer.
Andruska N; Zheng X; Yang X; Helferich WG; Shapiro DJ
Oncogene; 2015 Jul; 34(29):3760-9. PubMed ID: 25263449
[TBL] [Abstract][Full Text] [Related]
8. A New Anti-Estrogen Discovery Platform Identifies FDA-Approved Imidazole Anti-Fungal Drugs as Bioactive Compounds against ERα Expressing Breast Cancer Cells.
Cipolletti M; Bartoloni S; Busonero C; Parente M; Leone S; Acconcia F
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805656
[TBL] [Abstract][Full Text] [Related]
9. Lysosomal function is involved in 17β-estradiol-induced estrogen receptor α degradation and cell proliferation.
Totta P; Pesiri V; Marino M; Acconcia F
PLoS One; 2014; 9(4):e94880. PubMed ID: 24736371
[TBL] [Abstract][Full Text] [Related]
10. Protein kinase D1 regulates ERα-positive breast cancer cell growth response to 17β-estradiol and contributes to poor prognosis in patients.
Karam M; Bièche I; Legay C; Vacher S; Auclair C; Ricort JM
J Cell Mol Med; 2014 Dec; 18(12):2536-52. PubMed ID: 25287328
[TBL] [Abstract][Full Text] [Related]
11. Dynamin II is required for 17β-estradiol signaling and autophagy-based ERα degradation.
Totta P; Busonero C; Leone S; Marino M; Acconcia F
Sci Rep; 2016 Mar; 6():23727. PubMed ID: 27009360
[TBL] [Abstract][Full Text] [Related]
12. Selective impact of ALK and MELK inhibition on ERα stability and cell proliferation in cell lines representing distinct molecular phenotypes of breast cancer.
Bartoloni S; Pescatori S; Bianchi F; Cipolletti M; Acconcia F
Sci Rep; 2024 Apr; 14(1):8200. PubMed ID: 38589728
[TBL] [Abstract][Full Text] [Related]
13. The two-pore domain potassium channel KCNK5: induction by estrogen receptor alpha and role in proliferation of breast cancer cells.
Alvarez-Baron CP; Jonsson P; Thomas C; Dryer SE; Williams C
Mol Endocrinol; 2011 Aug; 25(8):1326-36. PubMed ID: 21680658
[TBL] [Abstract][Full Text] [Related]
14. Clinically relevant CHK1 inhibitors abrogate wild-type and Y537S mutant ERα expression and proliferation in luminal primary and metastatic breast cancer cells.
Pescatori S; Leone S; Cipolletti M; Bartoloni S; di Masi A; Acconcia F
J Exp Clin Cancer Res; 2022 Apr; 41(1):141. PubMed ID: 35418303
[TBL] [Abstract][Full Text] [Related]
15. Coactivator-mediated estrogen response in human squamous cell carcinoma lines.
Ku TK; Crowe DL
J Endocrinol; 2007 Apr; 193(1):147-55. PubMed ID: 17400812
[TBL] [Abstract][Full Text] [Related]
16. Estrogen receptor α attenuates therapeutic efficacy of paclitaxel on breast xenograft tumors.
Chang J; Sui M; Fan W
Breast Cancer Res Treat; 2012 Aug; 134(3):969-80. PubMed ID: 22374518
[TBL] [Abstract][Full Text] [Related]
17. Potentiation of paclitaxel effect by resveratrol in human breast cancer cells by counteracting the 17β-estradiol/estrogen receptor α/neuroglobin pathway.
Cipolletti M; Montalesi E; Nuzzo MT; Fiocchetti M; Ascenzi P; Marino M
J Cell Physiol; 2019 Apr; 234(4):3147-3157. PubMed ID: 30421506
[TBL] [Abstract][Full Text] [Related]
18. Harmful effect of ERβ on BCRP-mediated drug resistance and cell proliferation in ERα/PR-negative breast cancer.
Li W; Jia M; Qin X; Hu J; Zhang X; Zhou G
FEBS J; 2013 Dec; 280(23):6128-40. PubMed ID: 24103091
[TBL] [Abstract][Full Text] [Related]
19. Palmitoylation regulates 17β-estradiol-induced estrogen receptor-α degradation and transcriptional activity.
La Rosa P; Pesiri V; Leclercq G; Marino M; Acconcia F
Mol Endocrinol; 2012 May; 26(5):762-74. PubMed ID: 22446104
[TBL] [Abstract][Full Text] [Related]
20. Estrogen receptor alpha is cell cycle-regulated and regulates the cell cycle in a ligand-dependent fashion.
JavanMoghadam S; Weihua Z; Hunt KK; Keyomarsi K
Cell Cycle; 2016 Jun; 15(12):1579-90. PubMed ID: 27049344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
